Ignite Creation Date:
2024-05-05 @ 4:51 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00324298
Status:
COMPLETED
Last Update Posted:
2013-08-12
First Post:
2006-05-10
Brief Title:
Bleomycin Etoposide and Cisplatin in Treating Patients With Metastatic Germ Cell Cancer of the Testicles
Sponsor:
Queen Mary University of London
Organization:
National Cancer Institute NCI
Organization Data
Organization:
National Cancer Institute NCI
Class:
NIH
Study ID:
BARTS-TE3
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Queen Mary University of London
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None